Showing results (41-50 of 147) with videos related to
Sort By:
Pageof 15
Medical Oncology (Northwood, London, England)|December 2, 2022
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709XYue Hao, Manyi Xu, Huan Zhou, et al.Clinical Lung Cancer|December 18, 2018
De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective StudyZhengbo Song, Hong Wang, Zongyang Yu, et al.Translational Lung Cancer Research|November 14, 2025
Immune-oncology-microbiome axis in lung cancer: from carcinogenesis to therapy-a narrative reviewMengyi Shen, Yueying Chen, Jiayan Chen, et al.Food Chemistry|January 23, 2024
Contribution of lipid to the formation of characteristic volatile flavor of peanut oilYingchuan Ma, Kai Zhang, Chunwei Xu, et al.Clinical Medicine Insights. Oncology|July 26, 2026
The Prognostic Significance of BRCA1-Associated Protein 1(BAP1) in Malignant Pleural Mesothelioma: A Systematic Review and Meta-AnalysisJiaojiao Hong, Xianzi Dai, Jiangxia Yuan, et al.Investigational New Drugs|December 1, 2024
Efficacy of immune checkpoint inhibitor rechallenge in initial immunotherapy responders with advanced non-small cell lung cancer: A single-center retrospective studyManyi Xu, Yanhua Wang, Ke Wang, et al.Journal of Translational Medicine|February 23, 2019
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective studyWenxian Wang, Hong Wang, Peihua Lu, et al.Translational Lung Cancer Research|May 17, 2023
Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative reviewJiayan Chen, Chunwei Xu, Jiawen Lv, et al.Journal of Cancer|May 22, 2023
Role of Exosomes in the Invasion and Metastasis of Ovarian Cancer and Application Potential of Clinical Diagnosis and TreatmentYifei Zhu, Cheng Wang, Ziyu Ma, et al.BMC Pulmonary Medicine|May 5, 2023
Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutationsJinfei Si, Yue Hao, Jingwen Wei, et al.Pageof 15